drugset / Trial / NCT04715737

Differential Effects of Vasopressin and Oxytocin on Attention Control

NCT04715737

RandomizedParallel-groupTriple-blindBasic science

Summary

The main aim of the present study is to investigate whether intranasal vasopressin (20IU) and oxytocin (24IU) have differential effects on attention control in a social-emotional saccade/antisaccade eye-tracking paradigm.

Timeline

Start
2017-12-19
Primary completion
2021-01-01
Completion
2021-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 24 iu Intranasal
Subject Vasopressin Peptide 20 iu Intranasal

Indications

No indication recorded.